Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Slides:

Advertisements

Similar presentations

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Advertisements

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment Javier Domingo, M.D., Vicente.

Age at menarche: a predictor of diminished ovarian function?

Ureteral injury after transvaginal ultrasound-guided oocyte retrieval: a complication of in vitro fertilization-embryo transfer that may lurk undetected.

Local injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates Liang Zhou, M.D., Rong Li, M.D., Ph.D., Rong.

Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology.

Fertility and Sterility Volume 97, Issue 3, Pages (March 2012)

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Extremities of body mass index and their association with pregnancy outcomes in women undergoing in vitro fertilization in the United States Jennifer.

Michael M. Alper, M.D. Fertility and Sterility

Relationship between pre-embryo pronuclear morphology (zygote score) and standard day 2 or 3 embryo morphology with regard to assisted reproductive technique.

Patient-tailored ovarian stimulation for in vitro fertilization

Hysterosalpingography with use of mobile C-arm fluoroscopy

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D. Fertility and Sterility

Effect of the initiation of progesterone supplementation in in vitro fertilization–embryo transfer outcomes: a prospective randomized controlled trial

Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.

What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility.

L. G. Maldonado, W. C. Busato, L. M. Rossi, T. C. Bonetti, A

Ovarian stimulation protocols for IVF: is more better than less?

In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors Ahmad O. Hammoud, M.D.,

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Live birth of twins derived from zona-free oocytes

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes Jin-Ho Lim, M.D., Seong-Ho Yang,

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Martin D. Keltz, M. D. , Josh C. Skorupski, M. D. , Katrina Bradley, M

Oocyte cryopreservation

Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials Valeria M.S.

Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis Cui Hong Zheng, M.D., Ph.D.,

Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis Laura P. Smith, M.D.,

Clomiphene citrate at 50: the dawning of assisted reproduction

Mohamed Fawzy, M. D. , Mohamed Y. AbdelRahman, M. D. , Mohamed H

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Treatment of Ovarian Hyperstimulation Syndrome Utilizing a Dopamine Agonist and Gonadotropin Releasing Hormone antagonist N. Rollene, M. Amols, S. Hudson,

Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic.

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Thomas M. D’Hooghe, M. D. , Ph. D. , Bénédicte Denys, M. D

Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study Danielle.

Jennifer F. Kawwass, M. D. , Sara Crawford, Ph. D. , Donna R

Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success J. Ryan Martin, M.D., Jason G. Bromer,

Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D.

Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation Allison Styne-Gross, M.D., Karen.

José Bellver, M. D. , Yanira Ayllón, M. D. , Marcos Ferrando, M. D

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Cabergoline and Ganirelix Therapy for Early Moderate to Severe Ovarian Hyperstimulation Syndrome (OHSS) Results in Faster Recovery than in Early Untreated.

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.

Sedigheh Borna, M.D., Azita Nasery, M.D. Fertility and Sterility

Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr Murat Arslan, M.D.,

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Diane De Neubourg, M. D. , Kathelijne Mangelschots, B. Sc

In vitro sildenafil citrate use as a sperm motility stimulant

Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Contact among families who share the same sperm donor

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society.

Presentation transcript:

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward, M.D., Lan Lan, Ph.D., Anish A. Shah, M.D., M.H.S., Jason S. Yeh, M.D., Thomas M. Price, M.D., James M. Goldfarb, M.D., Suheil J. Muasher, M.D. Fertility and Sterility Volume 101, Issue 4, Pages 967-973 (April 2014) DOI: 10.1016/j.fertnstert.2013.12.026 Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Distribution of retrieved oocyte number per in vitro fertilization (IVF) cycle among Society for Assisted Reproductive Technology (SART) members from 2008 to 2010. Fertility and Sterility 2014 101, 967-973DOI: (10.1016/j.fertnstert.2013.12.026) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Percentages of ovarian hyperstimulation syndrome (OHSS) and live birth (LB) per retrieved oocyte numbers per IVF cycle among SART members from 2008 to 2010. Other abbreviations as in Figure 1. Fertility and Sterility 2014 101, 967-973DOI: (10.1016/j.fertnstert.2013.12.026) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Receiver operating characteristic curve for retrieved oocyte number as a predictor of ovarian hyperstimulation syndrome. Oocyte number thresholds: A: 5; B: 10; C: 15; D: 20; E: 25. Other abbreviations as in Figures 1 and 2. Fertility and Sterility 2014 101, 967-973DOI: (10.1016/j.fertnstert.2013.12.026) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions